Aug 11 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK :
* Voluntary announcement-further acquisition of approximately 10.69% equity
interest in guangxi yulin pharmaceutical group co., ltd. 1681.HK
* Subsidiary (a wholly-owned subsidiary of the company) has entered into the
equity transfer agreements with the sixth round vendors
* Deal for consideration of approximately RMB93.2 million
* Equity transfer agreements with the sixth round vendors during the period
from 20 July 2016 to 8 August 2016
* "Sixth Round Vendors" a total of 146 individuals, all of whom are citizens of the PRC
* "Subsidiary" (Guangzhou Consun Pharmaceutical Company Limited*), a wholly-owned subsidiary of the Company established in the PRC
* Source text (http://bit.ly/2aVa4HH)
* ((Further company coverage: 1681.HK ))
((Bangalore.newsroom@thomsonreuters.com))